English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech BioTech (Sci&Research)
US Tests Confirm Path-Away(R) Organically Kills SARS-CoV-2 Virus
Oct 21, 2020 21:00 HKT
Olympus to Support Endoscopic AI Diagnosis Education for Doctors in India and to Launch AI Diagnostic Support Application
Oct 20, 2020 10:00 HKT
中国生物制药副主席兼执行董事郑翔玲女士及执行董事谢炘先生合共增持公司70万股股份
Oct 19, 2020 17:20 HKT
中國生物製藥副主席兼執行董事鄭翔玲女士及執行董事謝炘先生合共增持公司70萬股股份
Oct 19, 2020 17:19 HKT
东曜药业股份有限公司完善公司管理架构 推动战略发展升级
Oct 16, 2020 09:02 HKT
東曜藥業股份有限公司完善公司管理架構 推動戰略發展升級
Oct 16, 2020 09:01 HKT
TOT BIOPHARM International Company Limited Optimises Company Management Structure to Promote Strategic Development Upgrade
Oct 16, 2020 09:00 HKT
华领医药宣布获得《药品生产许可证》
Oct 14, 2020 14:02 HKT
華領醫藥宣佈獲得《藥品生產許可證》
Oct 14, 2020 14:01 HKT
Hua Medicine Announces the Drug Manufacturing Permit Granted for Dorzagliatin
Oct 14, 2020 14:00 HKT
堃博C轮融资数千万美元 持续领跑肺部疾病精准介入治疗领域
Oct 14, 2020 12:02 HKT
堃博C輪融資數千萬美元 持續領跑肺部疾病精准介入治療領域
Oct 14, 2020 12:01 HKT
Broncus Closes Series C Financing
Oct 14, 2020 12:00 HKT
Olympus Launches ENDO-AID, an AI-Powered Platform for Its Endoscopy System
Oct 09, 2020 15:00 HKT
嘉和生物成功登陸香港聯交所主板
Oct 07, 2020 12:02 HKT
嘉和生物成功登陆香港联交所主板
Oct 07, 2020 12:00 HKT
天大藥業收購瑤池醫療及瑤池養生並達成深度合作
Oct 07, 2020 11:00 HKT
天大药业收购瑶池医疗及瑶池养生并达成深度合作
Oct 07, 2020 11:00 HKT
China Biotech Services (8037.HK) and National Institute for Viral Disease Control and Prevention (NIVDC) to develop Genetically Engineered Recombinant Vaccine for COVID-19
Oct 05, 2020 21:30 HKT
中国生物科技服务(8037.HK)与中国疾控中心病毒病研究所合作 开发新一代新冠病毒基因工程重组疫苗
Oct 05, 2020 20:04 HKT
Next >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: